Big Health vs Regeneron Pharmaceuticals
Side-by-side comparison of AI visibility scores, market position, and capabilities
$23.7M round in Feb 2026 led by .406 Ventures and AlleyCorp with CVS Health Ventures. Makers of Sleepio and Daylight — sleep and mental health DTx.
About
Big Health is a pioneer of prescription digital therapeutics for mental health and sleep. Its flagship products — Sleepio (insomnia) and Daylight (anxiety) — are both cognitive behavioral therapy (CBT) programs delivered as software, with randomized controlled trial evidence of clinical efficacy.
Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.
About
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.